XML 71 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity Based Plans
12 Months Ended
Dec. 31, 2012
Equity Based Plans, Preferred Stock and Common Stock [Abstract]  
Equity Based Plans

9. Equity Based Plans

The Company has the following equity based plans:

The 1992 Stock Option Plan, as amended (the “1992 Plan”), permitted the Company to grant to key employees and outside directors of the Company incentive and non-qualified options to purchase up to 3,495,000 shares of common stock (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The 1992 Plan expired in 2002 and no new option grants can be awarded subsequent to this date. At December 31, 2011 and 2012, there were no stock options outstanding under the 1992 Plan.

Incentive stock options (those intended to satisfy the requirements of the Internal Revenue Code) granted under the 1992 Plan were granted at an exercise price not less than the fair market value of the shares of common stock on the date of grant. The exercise prices of options granted under the 1992 Plan were determined by the Compensation Committee. The period within which each option is exercisable was determined by the Compensation Committee (however, in no event may the exercise period of an incentive stock option extend beyond 10 years from the date of grant).

The Amended and Restated 1999 Employee Stock Option Plan (the “Amended 1999 Plan”) permits the Company to grant to non-employee directors and employees of the Company up to 600,000 non-qualified options to purchase shares of common stock and restricted stock (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The exercise prices of options granted under the Amended 1999 Plan are determined by the Compensation Committee. The period within which each option will be exercisable is determined by the Compensation Committee. The Amended 1999 Plan was approved by the shareholders of the Company at the 2008 Shareholders Meeting on May 20, 2008.

 

During 2003, the Board of Directors of the Company (the “Board”) granted inducement options covering 145,000 options, respectively, to five individuals in connection with their offers of employment. As of December 31, 2011, 124,000 of the 145,000 options are outstanding. Inducement options may be exercised for a 10 year term from the date of the grant. As of December 31, 2012, there were no stock options outstanding under these inducement options.

The Amended and Restated 2003 Stock Option Plan (the “Amended 2003 Plan”) permits the Company to grant to key employees and outside directors of the Company incentive and non-qualified options and shares of restricted stock covering up to 1,250,000 shares of common stock (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The Amended 2003 Plan was approved by the shareholders of the Company at the 2010 Shareholders Meeting on May 18, 2010.

A cumulative summary of equity plans as of December 31, 2012 follows:

 

                                                 

Equity Plans

  Authorized     Restricted
Stock
Issued
    Outstanding
Stock
Options
    Stock
Options
Exercised
    Stock
Options
Exercisable
    Shares
Available
for Grant
 

1992 Plan

    3,495,000       —         —         2,796,012       —         —    

Amended 1999 Plan

    600,000       360,900       15,840       123,951       15,840       99,309  

Amended 2003 Plan

    1,250,000       253,400       60,000       718,300       60,000       218,300  

Inducements

    164,000       —         —         164,000       —         —    
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
      5,509,000       614,300       75,840       3,802,263       75,840       317,609  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

A summary of the status of the Company’s stock options granted under the plans as of December 31, 2012, 2011 and 2010 and the changes during the years then ended is presented below:

 

                                 
    Number of
Shares
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term
    Aggregate
Intrinsic
Value
(000’s)
 

Outstanding at December 31, 2009

    874,192       14.24       4.6 Years          

Granted

    —         —                    

Exercised

    (142,002     13.66                  

Cancelled

    (160     18.42                  

Forfeited

    (8,140     18.54                  
   

 

 

                         

Outstanding at December 31, 2010

    723,890       14.30       3.6 Years          

Granted

    —         —                    

Exercised

    (375,080     13.92                  

Cancelled

    —         —                    

Forfeited

    —         —                    
   

 

 

                         

Outstanding at December 31, 2011

    348,810       14.71       2.6 Years          
   

 

 

                         

Granted

    —                            

Exercised

    (272,750     14.12                  

Cancelled

    (220     17.89                  

Forfeited

    —         —                    
   

 

 

                         

Outstanding at December 31, 2012

    75,840       —         2.2 Years          
   

 

 

                         

Exercisable at December 31, 2012

    75,840       —         2.2 Years     $ 811  
   

 

 

                         

All shares pursuant to stock options were fully vested at December 31, 2012 and 2011.

 

A summary of the intrinsic value of stock options exercised during the years ended December 31, 2012, 2011 and 2010 is as follows:

 

                 
    Number
of Shares
    Aggregate
Intrinsic
Value
(000’)
 

2010

    142,002     $ 863  

2011

    375,080     $ 3,160  

2012

    272,750     $ 3,459  

The following tables summarize information about the Company’s stock options outstanding as of December 31, 2012, 2011 and 2010, respectively:

 

                                         
    Outstanding
Options as of
December 31,
2012
    Exercise Price     Weighted
Average
Remaining
Contractual
Life
    Exercisable     Exercise Price  

1999 Plan

    15,840     $ 12.60 – $18.42       2.2 Years       15,840     $ 12.60 – $18.42  

2003 Plan

    60,000     $ 12.51 – $18.80       2.2 Years       60,000     $ 12.51 – $18.80  
   

 

 

                   

 

 

         
      75,840     $ 12.51 – $18.80       2.2 Years       75,840     $ 12.51 – $18.80  
   

 

 

                   

 

 

         
           
    Outstanding
Options as of
December 31,
2011
    Exercise Price     Weighted
Average
Remaining
Contractual
Life
    Exercisable     Exercise Price  

1999 Plan

    17,310     $ 12.60 – $18.42       3.2 Years       17,310     $ 12.60 – $18.42  

2003 Plan

    251,500     $ 12.51 – $18.80       2.9 Years       251,500     $ 12.51 – $18.80  

Inducements

    80,000     $ 12.75 – $14.32       1.7 Years       80,000     $ 12.75 – $14.32  
   

 

 

                   

 

 

         
      348,810     $ 12.51 – $18.80       2.6 Years       348,810     $ 12.51 – $18.80  
   

 

 

                   

 

 

         
           
    Outstanding
Options as of
December 31,
2010
    Exercise Price     Weighted
Average
Remaining
Contractual
Life
    Exercisable     Exercise Price  

1992 Plan

    15,000     $ 16.34       .6 Years       15,000     $ 16.34  

1999 Plan

    43,390     $ 12.60 – $18.42       3.9 Years       43,390     $ 12.60 – $18.42  

2003 Plan

    541,500     $ 12.51 – $18.80       3.8 Years       541,500     $ 12.51 – $18.80  

Inducements

    124,000     $ 12.75 – $14.32       2.8 Years       124,000     $ 12.75 – $14.32  
   

 

 

                   

 

 

         
      723,890     $ 12.51 – $18.80       3.6 Years       723,890     $ 12.51 – $18.80  
   

 

 

                   

 

 

         

The following table summarizes information about the Company’s stock options outstanding and those options that are exercisable as of December 31, 2012:

 

                 

Range of Exercise Prices

  Outstanding
Options
    Exercisable
Options
 

$12.00 – $12.99

    11,790       11,790  

$14.00 – $14.99

    2,500       2,500  

$15.00 – $15.99

    12,550       12,550  

$18.00 – $18.80

    49,000       49,000  
   

 

 

   

 

 

 
      75,840       75,840  
   

 

 

   

 

 

 

 

During 2012, 2011 and 2010, the Company granted the following shares (net of those shares cancelled in their respective grant year due to employee terminations prior to restrictions lapsing) of restricted stock to directors, officers and employees pursuant to its equity plans as follows:

 

                 

Year Granted

  Number of
Shares
    Weighted
Average
Fair Value
Per Share
 

2010

    84,400     $ 16.53  

2011

    156,750     $ 19.94  

2012

    80,650     $ 21.65  

Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following four or five anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the first year after the date of grant. For those granted to executive officers, the restriction will lapse in equal quarterly installments during the three to four years following the date of grant.

As of December 31, 2012, there were 187,170 shares outstanding for which restrictions had not lapsed. The restrictions will lapse in 2013 through 2016.

Compensation expense for grants of restricted stock will be recognized based on the fair value on the date of grant. Compensation expense for restricted stock grants was $2,102,000, $2,032,000 and $1,245,000, respectively, for 2012, 2011 and 2010. As of December 31, 2012, the remaining $2.8 million of compensation expense will be recognized from 2013 through 2016.